Medically reviewed by Forest Miller, OTR/L When you are managing metastatic breast cancer, planning for the future is both ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Researchers aim to validate the AI tool SCORPIO in prospective studies and eventually seek FDA clearance to sell it as a commercial tool in the US.

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

Cancer accounted for nearly 10 million deaths in 2020 – almost one in every six deaths globally – according to the World Health Organization.

In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

Cancer accounted for nearly 10 million deaths in 2020 – almost one in every six deaths globally – according to the World ...

I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One ...

Prostate cancer kills 35,000 men a year, according to Dr. Roach. But not all cancers are treated the same way.

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side ...